DXRX logo

Diaceutics PLC Stock Price

AIM:DXRX Community·UK£135.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author

DXRX Share Price Performance

UK£1.61
0.38 (31.02%)
UK£1.61
0.38 (31.02%)
Price UK£1.61

DXRX Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet and good value.

0 Risks
3 Rewards

Diaceutics PLC Key Details

UK£34.4m

Revenue

UK£4.8m

Cost of Revenue

UK£29.6m

Gross Profit

UK£31.1m

Other Expenses

-UK£1.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.018
86.12%
-4.42%
0%
View Full Analysis

About DXRX

Founded
2005
Employees
213
CEO
Ryan Keeling
WebsiteView website
www.diaceutics.com

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Recent DXRX News & Updates

Recent updates

No updates